DaVita Inc.

XNYSHealth care

Last traded price · USD

$192.66

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $192.66
Volume: —
Day's high: —
Day's low: —

In brief

DaVita Inc. is a health care company listed on the New York Stock Exchange, valued at about $12.12B.
Its shares closed at $192.66 on 4 Nov 2026, up 60.6% over the past year.
From India you can buy DVA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy DaVita Inc. (DVA) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole DVA share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade DVA options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +6.8% (SPY −1.6%, XLV +13.5%). 3 months: +2.1% (SPY −0.4%, XLV +15.5%). 1 year: +60.6% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: DVA, SPY and XLV · as of 4 Nov 2026
9.7 days to cover short interest
4.9M shares were sold short at the 15 Oct 2026 settlement, 7.8% of the 62.9M shares outstanding; covering them would take 9.7 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $192.66 was 5.8% above its 50-day average ($182.05) and 8.1% above its 200-day average ($178.24). It has closed above the 200-day for 191 sessions, since 3 Feb 2026. The 50-day average crossed above the 200-day on 13 Mar 2026, 163 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
63% of the way up its 52-week range
Closed at $192.66 on 4 Nov 2026: 22.2% below the 52-week high of $247.49 (3 Aug 2026) and 90.8% above the low of $101.00 (14 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 1.6× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 1.2M shares was 1.6× the average of the 30 sessions before it (724.1K), as the price rose 5.8%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+6.8%

6 months−0.6%

1 year+60.6%

5 years+84.8%

Newswire

About

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Website

Notable moves

May 6, 2026
+23.46%
February 3, 2026
+21.17%
October 28, 2022
−27.09%

DaVita Inc.

XNYSHealth care

Last traded price · USD

$192.66

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $192.66
Volume: —
Day's high: —
Day's low: —

In brief

DaVita Inc. is a health care company listed on the New York Stock Exchange, valued at about $12.12B.
Its shares closed at $192.66 on 4 Nov 2026, up 60.6% over the past year.
From India you can buy DVA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy DaVita Inc. (DVA) shares from India?

Do I need the price of a whole DVA share to invest?

How much can I invest in US stocks in a year?

Can I trade DVA options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +6.8% (SPY −1.6%, XLV +13.5%). 3 months: +2.1% (SPY −0.4%, XLV +15.5%). 1 year: +60.6% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: DVA, SPY and XLV · as of 4 Nov 2026
9.7 days to cover short interest
4.9M shares were sold short at the 15 Oct 2026 settlement, 7.8% of the 62.9M shares outstanding; covering them would take 9.7 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $192.66 was 5.8% above its 50-day average ($182.05) and 8.1% above its 200-day average ($178.24). It has closed above the 200-day for 191 sessions, since 3 Feb 2026. The 50-day average crossed above the 200-day on 13 Mar 2026, 163 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
63% of the way up its 52-week range
Closed at $192.66 on 4 Nov 2026: 22.2% below the 52-week high of $247.49 (3 Aug 2026) and 90.8% above the low of $101.00 (14 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 1.6× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 1.2M shares was 1.6× the average of the 30 sessions before it (724.1K), as the price rose 5.8%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+6.8%

6 months−0.6%

1 year+60.6%

5 years+84.8%

Newswire

About

Website

Notable moves

May 6, 2026
+23.46%
February 3, 2026
+21.17%
October 28, 2022
−27.09%

DaVita Inc.

DaVita Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

9.7 days to cover short interest

Above its 50- and 200-day averages

63% of the way up its 52-week range

Volume 1.6× its 30-session average on 4 Nov 2026

DaVita Inc.

DaVita Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

9.7 days to cover short interest

Above its 50- and 200-day averages

63% of the way up its 52-week range

Volume 1.6× its 30-session average on 4 Nov 2026